Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Cataract-aberrant oral frenula-growth delay syndrome is characterized by cataracts and short stature associated with variable anomalies, including aberrant oral frenula, a characteristic facial appearance (posteriorly angulated ears, upslanting palpebral fissures, small nose, ptosis and epicanthal folds) cavernous hemangiomas and hernias. It has been described in a mother and her two children. It is transmitted as an autosomal dominant trait.
Estimated prevalence: <1 in 1,000,000 (VERY_RARE).
No clinical trials have been registered for cataract-aberrant oral frenula-growth delay syndrome.
300 publications have been identified in PubMed for cataract-aberrant oral frenula-growth delay syndrome. Kisho has analyzed 13 by research type. Research spans Review / Meta-Analysis (46%), Other (23%), and Case Report / Case Series (15%).
Research Type | Count | % of Total |
|---|---|---|
Research summaries | 6 | 46% |
Data assembled from 4 of 12 sources · Last updated Sep 20, 2026, 5:38 PM UTC
Patient Advocacy Groups (PAGs) provide support, resources, and community for patients and caregivers.
Online Mendelian Inheritance in Man
European rare disease database
Genetic and Rare Diseases Info Center
Other research |
3 |
23% |
Patient case studies | 2 | 15% |
Laboratory research | 2 | 15% |
Wolbert JG (2026). [PMID: 32644370](https://pubmed.ncbi.nlm.nih.gov/32644370/). *Unknown Journal*. [Other]
Bhandari J (2026). [PMID: 32491445](https://pubmed.ncbi.nlm.nih.gov/32491445/). *Unknown Journal*. [Other]
Pillarisetti L (2025). [PMID: 39902055](https://pubmed.ncbi.nlm.nih.gov/39902055/). *Arch Intern Med Res*. [Other]
Hong GW (2025). [PMID: 40062708](https://pubmed.ncbi.nlm.nih.gov/40062708/). *J Cosmet Dermatol*. [Review / Meta-Analysis]
Howard MD (2025). [PMID: 40183300](https://pubmed.ncbi.nlm.nih.gov/40183300/). *Curr Opin Obstet Gynecol*. [Review / Meta-Analysis]
Loli P (2025). [PMID: 40699527](https://pubmed.ncbi.nlm.nih.gov/40699527/). *Endocrine*. [Review / Meta-Analysis]
Okamoto N (2025). [PMID: 40546132](https://pubmed.ncbi.nlm.nih.gov/40546132/). *Am J Med Genet A*. [Case Report / Case Series]
Nguyen KA (2024). [PMID: 38518106](https://pubmed.ncbi.nlm.nih.gov/38518106/). *Blood*. [Basic Science / Preclinical]
DeBattista C (2024). [PMID: 38993656](https://pubmed.ncbi.nlm.nih.gov/38993656/). *Psychopharmacol Bull*. [Review / Meta-Analysis]
Yu WR (2024). [PMID: 39335564](https://pubmed.ncbi.nlm.nih.gov/39335564/). *Biomedicines*. [Review / Meta-Analysis]